"Jannie Beier er speciallæge i reumatologi og har siden 1997 haft klinik i Skt. Anne Lægehus midt i Odense centrum. Som din lokale reumatolog i Odense undersøger og behandler hun en lang række forskelligartede sygdomme i bevægeapparatet. Funktionsnedsættende lidelser kan have mange forskellige årsager og symptomer. Med over 20 års erfaring i egen speciallægepraksis har Jannie Beier netop den ekspertise og erfaring det kræver at diagnosticere og behandle smerter i nakke, ryg, arme og ben. Hun er desuden specialiseret i medicinske gigtlidelser samt overbelastningsskader i bevægeapparatet."

During the past decade, Reumatolog i Odense conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Reumatolog i Odense" are "Osteoarthritis, Knee" (2 trials). Many other conditions were trialed in "Reumatolog i Odense" in a lesser frequency.

Most popular intervention types in "Reumatolog i Odense" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "PAAG-OA" (2 trials) and "Synvisc-One" (1 trials). Other intervention names were less common.

The vast majority of trials in "Reumatolog i Odense" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Reumatolog i Odense". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Reumatolog i Odense, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Reumatolog i Odense, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".